{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:30:03Z","timestamp":1776778203193,"version":"3.51.2"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018778","name":"Al-Azhar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Early pancreatic cancer (PC) identification and management has gained much clinical and research attention. Recent reports have demonstrated the important function of circulating noncoding RNAs (ncRNAs) in the diagnosis and prognosis of malignancies. However, the clinical value of serum ncRNAs in PC has not been fully clarified. Hence, we investigated serum levels of long-ncRNA NEAT1 and miR-129-5p in PC cases, exploring their relationship with related targets BCL2 and TGF-\u03b21. Serum NEAT1 and miR-129-5p levels were evaluated in 60 treatment-na\u00efve PC cases and 30 apparent healthy individuals by RT-PCR. Besides, serum TGF-\u03b21 and BCL2 levels were measured by ELISA, whereas CA19-9 and CEA were measured utilizing the chemiluminescence technique. We demonstrated that serum NEAT1, BCL2, and TGF-\u03b21 levels were significantly upregulated, whereas serum levels of miR-129-5p were markedly reduced in PC cases compared to controls. miR-129-5p had a higher diagnostic value for PC than NEAT1, with specificity, sensitivity, and AUC of 100%, 95%, and 0.96 versus 93.3%, 83.3%, and 0.89, respectively. Moreover, miR-129-5p had a higher AUC than CA19-9 and CEA. Additionally, serum miR-129-5p was significantly downregulated in PC cases with T3 or T4 stages compared to those with T2 stage &amp; negatively correlated with NEAT1, BCL2, and TGF-\u03b21, whereas NEAT1 was notably positively correlated with BCL2 and TGF-\u03b21. Collectively, serum NEAT1 and miR-129-5p could be beneficial biomarkers for the detection of PC. Also, our findings accentuate the correlation between NEAT1, miR-129-5p, BCL2, and TGF-\u03b21 and provide PC therapeutic targets.<\/jats:p>","DOI":"10.1038\/s41598-025-12963-y","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T12:50:42Z","timestamp":1753793442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Hadeer Saied","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha Abdel-Rahman","family":"Eldesoky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0153-6555","authenticated-orcid":false,"given":"Ahmed A.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"12963_CR1","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3390\/cancers15143634","volume":"15","author":"O Partyka","year":"2023","unstructured":"Partyka, O. et al. Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations. Cancers 15, 3634. https:\/\/doi.org\/10.3390\/cancers15143634 (2023).","journal-title":"Cancers"},{"key":"12963_CR2","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s10620-024-08465-y","volume":"69","author":"H An","year":"2024","unstructured":"An, H., Dai, H. & Liu, X. Changing trends in the global disease burden of pancreatic cancer from 1990 to 2030. Dig. Dis. Sci. 69, 2450\u20132461. https:\/\/doi.org\/10.1007\/s10620-024-08465-y (2024).","journal-title":"Dig. Dis. Sci."},{"key":"12963_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-023-01870-3","volume":"22","author":"K Wang","year":"2023","unstructured":"Wang, K., Wang, X., Pan, Q. & Zhao, B. Liquid biopsy techniques and pancreatic cancer: Diagnosis, monitoring, and evaluation. Mol. Cancer22, 167. https:\/\/doi.org\/10.1186\/s12943-023-01870-3 (2023).","journal-title":"Mol. Cancer"},{"key":"12963_CR4","doi-asserted-by":"publisher","first-page":"115601","DOI":"10.1016\/j.biopha.2023.115601","volume":"167","author":"B Wang","year":"2023","unstructured":"Wang, B., Yuan, C., Qie, Y. & Dang, S. Long non-coding RNAs and pancreatic cancer: A multifaceted view. Biomed. Pharmacother. 167, 115601. https:\/\/doi.org\/10.1016\/j.biopha.2023.115601 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"12963_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.55705\/cmbr.2022.360799.1062","volume":"2","author":"H Alsaedy","year":"2023","unstructured":"Alsaedy, H., Mirzaei, A. & Alhashimi, R. A. Investigating the structure and function of long Non-Coding RNA (LncRNA) and its role in cancer. Cell. Mol. Biomedical Rep. 2, 245\u2013253. https:\/\/doi.org\/10.55705\/cmbr.2022.360799.1062 (2023).","journal-title":"Cell. Mol. Biomedical Rep."},{"key":"12963_CR6","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/cancers16152728","volume":"16","author":"M Kafida","year":"2024","unstructured":"Kafida, M., Karela, M. & Giakountis, A. RNA-independent regulatory functions of lncRNA in complex disease. Cancers16, 2728. https:\/\/doi.org\/10.3390\/cancers16152728 (2024).","journal-title":"Cancers"},{"key":"12963_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00018-023-04842-4","volume":"80","author":"KI Ivanov","year":"2023","unstructured":"Ivanov, K. I., Samuilova, O. V. & Zamyatnin, A. A. Jr The emerging roles of long noncoding RNAs in lymphatic vascular development and disease. Cell. Mol. Life Sci. 80, 197. https:\/\/doi.org\/10.1007\/s00018-023-04842-4 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"12963_CR8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/cbdd.14006","volume":"101","author":"F Malakoti","year":"2023","unstructured":"Malakoti, F. et al. Multiple function of LncRNA MALAT1 in cancer occurrence and progression. Chem. Biol. Drug Des. 101, 1113\u20131137. https:\/\/doi.org\/10.1111\/cbdd.14006 (2023).","journal-title":"Chem. Biol. Drug Des."},{"key":"12963_CR9","unstructured":"Liu, P. et al. Serum lncRNA-UFC1 as a potential biomarker for diagnosis and prognosis of pancreatic cancer. International Journal of Clinical and Experimental Pathology 12, 4125\u20134129 PMID: 31933809 (2019)."},{"key":"12963_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154438","volume":"245","author":"TM Al-Noshokaty","year":"2023","unstructured":"Al-Noshokaty, T. M. et al. Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-A review. Pathology-Research Pract.\u00a0245, 154438. https:\/\/doi.org\/10.1016\/j.prp.2023.154438 (2023).","journal-title":"Pathology"},{"key":"12963_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molcel.2009.01.026","volume":"33","author":"CM Clemson","year":"2009","unstructured":"Clemson, C. M. et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell33, 717\u2013726. https:\/\/doi.org\/10.1016\/j.molcel.2009.01.026 (2009).","journal-title":"Mol. Cell"},{"key":"12963_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.bbrc.2016.11.120","volume":"482","author":"B Huang","year":"2017","unstructured":"Huang, B. et al. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Biochem. Biophys. Res. Commun.482, 828\u2013834. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.120 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12963_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6510571","volume":"2023","author":"R Wu","year":"2023","unstructured":"Wu, R. et al. Extracellular vesicle-loaded oncogenic lncRNA NEAT1 from adipose-derived mesenchymal stem cells confers gemcitabine resistance in pancreatic cancer via miR-491-5p\/snail\/SOCS3 axis. Stem Cells Int.2023, 510571. https:\/\/doi.org\/10.1155\/2023\/6510571 (2023).","journal-title":"Stem Cells Int."},{"key":"12963_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098095","volume":"24","author":"H Schwarzenbach","year":"2023","unstructured":"Schwarzenbach, H. & Gahan, P. B. Interplay between lncRNAs and microRNAs in breast cancer. Int. J. Mol. Sci.24, 8095. https:\/\/doi.org\/10.3390\/ijms24098095 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"12963_CR15","doi-asserted-by":"publisher","first-page":"1299249","DOI":"10.3389\/fonc.2024.1299249","volume":"14","author":"H Xu","year":"2024","unstructured":"Xu, H., Li, W. & Wang, D. The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma. Front. Oncol.14, 1299249. https:\/\/doi.org\/10.3389\/fonc.2024.1299249 (2024).","journal-title":"Front. Oncol."},{"key":"12963_CR16","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1038\/cddis.2013.193","volume":"4","author":"M Karaayvaz","year":"2013","unstructured":"Karaayvaz, M., Zhai, H. & Ju, J. MiR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death Dis.4, e659. https:\/\/doi.org\/10.1038\/cddis.2013.193 (2013).","journal-title":"Cell Death Dis."},{"key":"12963_CR17","unstructured":"Li, Y. et al. MicroRNA profiling identifies miR-129-5p as a regulator of EMT in tubular epithelial cells. International journal of clinical and experimental medicine 8, 20610\u201320616 PMID: 26884980 (2015)."},{"key":"12963_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/01902148.2018.1536174","volume":"44","author":"C Bin","year":"2018","unstructured":"Bin, C., Xiaofeng, H. & Wanzi, X. The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism. Exp. Lung Res. 44, 280\u2013287. https:\/\/doi.org\/10.1080\/01902148.2018.1536174 (2018).","journal-title":"Exp. Lung Res."},{"key":"12963_CR19","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.26355\/eurrev_202008_22661","volume":"24","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Yao, X. H., Wu, Y., Cao, G. K. & Han, D. LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-\u03b2 signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 24, 8483\u20138492. https:\/\/doi.org\/10.26355\/eurrev_202008_22661 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"12963_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.semcancer.2012.04.002","volume":"22","author":"A Moustakas","year":"2012","unstructured":"Moustakas, A. & Heldin, C. H. Induction of epithelial\u2013mesenchymal transition by transforming growth factor \u03b2. Semin. Cancer Biol.22, 446\u2013454. https:\/\/doi.org\/10.1016\/j.semcancer.2012.04.002 (2012).","journal-title":"Semin. Cancer Biol."},{"key":"12963_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28193-4","volume":"8","author":"L Cong","year":"2018","unstructured":"Cong, L. et al. Tumor size classification of the 8th edition of TNM staging system is superior to that of the 7th edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy. Sci. Rep.8, 10383. https:\/\/doi.org\/10.1038\/s41598-018-28193-4 (2018).","journal-title":"Sci. Rep."},{"key":"12963_CR22","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/modpathol.3800685","volume":"20","author":"RH Hruban","year":"2007","unstructured":"Hruban, R. H. & Fukushima, N. Pancreatic adenocarcinoma: Update on the surgical pathology of carcinomas of ductal origin and PanINs. Mod. Pathol.20, S61\u2013S70. https:\/\/doi.org\/10.1038\/modpathol.3800685 (2007).","journal-title":"Mod. Pathol."},{"key":"12963_CR23","unstructured":"Cao, J. et al. NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p\/c-met axis. American journal of cancer research 6, 2361\u20132374 PMID: 27822425 (2016)."},{"key":"12963_CR24","first-page":"237","volume":"10","author":"Y Feng","year":"2020","unstructured":"Feng, Y., Gao, L., Cui, G. & Cao, Y. LncRNA NEAT1 facilitates pancreatic cancer growth and metastasis through stabilizing ELF3 mRNA. Am. J. Cancer Res. 10, 237\u2013248 (2020). PMID: 32064164.","journal-title":"Am. J. Cancer Res."},{"key":"12963_CR25","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.7150\/jca.58824","volume":"12","author":"H Hu","year":"2021","unstructured":"Hu, H. et al. NEAT1\/miR-101-dependent up-regulation of DNA-PKcs enhances malignant behaviors of pancreatic ductal adenocarcinoma cells. J. Cancer.12, 5622\u20135632. https:\/\/doi.org\/10.7150\/jca.58824 (2021) (PMID: 34405022).","journal-title":"J. Cancer."},{"key":"12963_CR26","doi-asserted-by":"publisher","first-page":"G150","DOI":"10.1152\/ajpgi.00426.2016","volume":"313","author":"L Fang","year":"2017","unstructured":"Fang, L. et al. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-I\u03baB. American Journal of Physiology-Gastrointestinal and Liver Physiology313, G150\u2013G156. https:\/\/doi.org\/10.1152\/ajpgi.00426.2016 (2017).","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"12963_CR27","first-page":"6692","volume":"10","author":"H Li","year":"2017","unstructured":"Li, H., Zheng, P., Xu, P., Li, Z. & Han, Q. Long non-coding RNA NEAT1 promotes human clear cell kidney carcinoma progression through negative regulation of miR-129-5p. Int. J. Clin. Exp. Pathol.10, 6692\u20136700 (2017).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"12963_CR28","unstructured":"Zhang, B., Li, C. & Sun, Z. Long non-coding RNA LINC00346, LINC00578, LINC00673, LINC00671, LINC00261, and SNHG9 are novel prognostic markers for pancreatic cancer. American journal of translational research 10, 2648\u20132658 PMID: 30210701 (2018)."},{"key":"12963_CR29","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.3748\/wjg.v25.i46.6728","volume":"25","author":"ZL Ou","year":"2019","unstructured":"Ou, Z. L., Luo, Z. & Lu, Y. B. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. World J. Gastroenterol.25, 6728\u20136742. https:\/\/doi.org\/10.3748\/wjg.v25.i46.6728 (2019).","journal-title":"World J. Gastroenterol."},{"key":"12963_CR30","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.26355\/eurrev_201809_15917","volume":"22","author":"X Guo","year":"2018","unstructured":"Guo, X., Yin, H. & Wang, J. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma. Eur. Rev. Med. Pharmacol. Sci. 22, 5892\u20135898. https:\/\/doi.org\/10.26355\/eurrev_201809_15917 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"12963_CR31","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/cancers12061693","volume":"12","author":"I Flammang","year":"2020","unstructured":"Flammang, I. et al. Tumor-suppressive miR-192-5p has prognostic value in pancreatic ductal adenocarcinoma. Cancers 12, 1693. https:\/\/doi.org\/10.3390\/cancers12061693 (2020).","journal-title":"Cancers"},{"key":"12963_CR32","doi-asserted-by":"publisher","first-page":"783231","DOI":"10.3389\/fonc.2021.783231","volume":"11","author":"R Yehia","year":"2021","unstructured":"Yehia, R. et al. Impact of TNF-\u03b1 gene polymorphisms on pancreatic and non-small cell lung cancer-induced cachexia in adult Egyptian patients: A focus on pathogenic trajectories. Front. Oncol.11, 783231. https:\/\/doi.org\/10.3389\/fonc.2021.783231 (2021).","journal-title":"Front. Oncol."},{"key":"12963_CR33","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20165485","volume":"49","author":"J Zhao","year":"2016","unstructured":"Zhao, J. et al. Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma. Braz. J. Med. Biol. Res.49, e5485. https:\/\/doi.org\/10.1590\/1414-431X20165485 (2016).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"12963_CR34","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"LM McShane","year":"2005","unstructured":"McShane, L. M. et al. Reporting recommendations for tumor marker prognostic studies. J. Clin. Oncol.23, 9067\u20139072. https:\/\/doi.org\/10.1200\/JCO.2004.01.0454 (2005).","journal-title":"J. Clin. Oncol."},{"key":"12963_CR35","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/medicina60071070","volume":"60","author":"S Dallavalle","year":"2024","unstructured":"Dallavalle, S. et al. New frontiers in pancreatic cancer management: Current treatment options and the emerging role of neoadjuvant therapy. Medicina60, 1070. https:\/\/doi.org\/10.3390\/medicina60071070 (2024).","journal-title":"Medicina"},{"key":"12963_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118518","volume":"262","author":"HA El-Mahdy","year":"2020","unstructured":"El-Mahdy, H. A., El-Husseiny, A. A., Kandil, Y. I. & El-Din, A. M. G. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. Life Sci.262, 118518. https:\/\/doi.org\/10.1016\/j.lfs.2020.118518 (2020).","journal-title":"Life Sci."},{"key":"12963_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Early screening and diagnosis strategies of pancreatic cancer: A comprehensive review. Cancer Commun.41, 1257\u20131274. https:\/\/doi.org\/10.1002\/cac2.12204 (2021).","journal-title":"Cancer Commun."},{"key":"12963_CR38","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.7150\/jca.32052","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis. J. Cancer.10, 3746\u20133756. https:\/\/doi.org\/10.7150\/jca.32052 (2019).","journal-title":"J. Cancer."},{"key":"12963_CR39","doi-asserted-by":"publisher","unstructured":"Abulsoud, A. I. et al. Investigating the regulatory role of MiRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer. Pathology-Research Pract. 154855 https:\/\/doi.org\/10.1016\/j.prp.2023.154855 (2023).","DOI":"10.1016\/j.prp.2023.154855"},{"key":"12963_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1878-0261.12404","volume":"13","author":"C Klec","year":"2019","unstructured":"Klec, C., Prinz, F. & Pichler, M. Involvement of the long noncoding RNA NEAT 1 in carcinogenesis. Mol. Oncol.13, 46\u201360. https:\/\/doi.org\/10.1002\/1878-0261.12404 (2019).","journal-title":"Mol. Oncol."},{"key":"12963_CR41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/1874467214666210914122010","volume":"15","author":"S Xu","year":"2022","unstructured":"Xu, S. et al. The role of miR-129-5p in cancer: A novel therapeutic target. Curr. Mol. Pharmacol.15, 647\u2013657. https:\/\/doi.org\/10.2174\/1874467214666210914122010 (2022).","journal-title":"Curr. Mol. Pharmacol."},{"key":"12963_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-024-01001-0","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8\/miR-181a-5p axis. Cell. Oncol.https:\/\/doi.org\/10.1007\/s13402-024-01001-0 (2024).","journal-title":"Cell. Oncol."},{"key":"12963_CR43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/abbs\/gmz096","volume":"51","author":"Z Qiu","year":"2019","unstructured":"Qiu, Z., Wang, X., Shi, Y. & Da, M. MiR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Acta Biochim. Biophys. Sin.51, 997\u20131007. https:\/\/doi.org\/10.1093\/abbs\/gmz096 (2019).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"12963_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/biom11020301","volume":"11","author":"AAA El-Fattah","year":"2021","unstructured":"El-Fattah, A. A. A., Sadik, N. A. H., Shaker, O. G. & Kamal, M. Shahin, N. N. Serum long non-coding RNAs PVT1, HOTAIR, and NEAT1 as potential biomarkers in Egyptian women with breast cancer. Biomolecules 11, 301. https:\/\/doi.org\/10.3390\/biom11020301 (2021).","journal-title":"Biomolecules"},{"key":"12963_CR45","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/iub.2096","volume":"71","author":"OG Shaker","year":"2019","unstructured":"Shaker, O. G. et al. Evaluation of serum long noncoding RNA NEAT and miR-129\u20105p in hepatocellular carcinoma. IUBMB Life71, 1571\u20131578. https:\/\/doi.org\/10.1002\/iub.2096 (2019).","journal-title":"IUBMB Life"},{"key":"12963_CR46","doi-asserted-by":"publisher","unstructured":"Wang, Y., Zhang, D., Zhang, C. & Sun, Y. The diagnostic and prognostic value of serum LncRNA NEAT1 in colorectal cancer. Cancer Manage. Res. 10985\u201310992. https:\/\/doi.org\/10.2147\/CMAR.S269978 (2020).","DOI":"10.2147\/CMAR.S269978"},{"key":"12963_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12253-016-0172-4","volume":"23","author":"W Peng","year":"2017","unstructured":"Peng, W., Wang, Z. & Fan, H. LncRNA NEAT1 impacts cell proliferation and apoptosis of colorectal cancer via regulation of Akt signaling. Pathol. Oncol. Res. 23, 651\u2013656. https:\/\/doi.org\/10.1007\/s12253-016-0172-4 (2017).","journal-title":"Pathol. Oncol. Res."},{"key":"12963_CR48","doi-asserted-by":"publisher","first-page":"537120","DOI":"10.3389\/fonc.2020.537120","volume":"10","author":"S Yuan","year":"2020","unstructured":"Yuan, S. et al. Circulating long noncoding RNAs act as diagnostic biomarkers in non-small cell lung cancer. Front. Oncol. 10, 537120. https:\/\/doi.org\/10.3389\/fonc.2020.537120 (2020).","journal-title":"Front. Oncol."},{"key":"12963_CR49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/life11040320","volume":"11","author":"D Nitusca","year":"2021","unstructured":"Nitusca, D. et al. Long noncoding RNA NEAT1 as a potential candidate biomarker for prostate cancer. Life 11, 320. https:\/\/doi.org\/10.3390\/life11040320 (2021).","journal-title":"Life"},{"key":"12963_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12967-022-03273-2","volume":"20","author":"J Liang","year":"2022","unstructured":"Liang, J., Liu, C., Xu, D., Xie, K. & Li, A. LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1. J. Translational Med. 20, 80. https:\/\/doi.org\/10.1186\/s12967-022-03273-2 (2022).","journal-title":"J. Translational Med."},{"key":"12963_CR51","doi-asserted-by":"publisher","first-page":"630262","DOI":"10.3389\/fcell.2021.630262","volume":"9","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. Pancreatic cancer progression is regulated by IPO7\/p53\/LncRNA MALAT1\/MiR-129-5p positive feedback loop. Front. Cell. Dev. Biology. 9, 630262. https:\/\/doi.org\/10.3389\/fcell.2021.630262 (2021).","journal-title":"Front. Cell. Dev. Biology"},{"key":"12963_CR52","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3892\/ol.2020.11827","volume":"20","author":"J Xue","year":"2020","unstructured":"Xue, J. et al. Expression of miR-129-5p and miR-433 in the serum of breast cancer patients and their relationship with clinicopathological features. Oncol. Lett.20, 2771\u20132778. https:\/\/doi.org\/10.3892\/ol.2020.11827 (2020).","journal-title":"Oncol. Lett."},{"key":"12963_CR53","unstructured":"Guo, S. et al. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. International journal of clinical and experimental pathology 8, 5395\u20135402 PMID: 26191242 (2015)."},{"key":"12963_CR54","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.7314\/APJCP.2015.16.7.2851","volume":"16","author":"LJ Pan","year":"2015","unstructured":"Pan, L. J. et al. Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues. Asian Pac. J. Cancer Prev. 16, 2851\u20132855. https:\/\/doi.org\/10.7314\/APJCP.2015.16.7.2851 (2015).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"12963_CR55","doi-asserted-by":"publisher","first-page":"27641","DOI":"10.18632\/oncotarget.4737","volume":"6","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget 6, 27641\u201327650. https:\/\/doi.org\/10.18632\/oncotarget.4737 (2015).","journal-title":"Oncotarget"},{"key":"12963_CR56","unstructured":"Zhang, M., Wu, W. B., Wang, Z. W. & Wang, X. H. lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT. European Review for Medical & Pharmacological Sciences 21, 1020\u20131026 PMID: 28338194 (2017)."},{"key":"12963_CR57","doi-asserted-by":"publisher","unstructured":"Fesler, A., Zhai, H. & Ju, J. miR-129 as a novel therapeutic target and biomarker in Gastrointestinal cancer. OncoTargets Therapy. 1481\u20131485. https:\/\/doi.org\/10.2147\/OTT.S65548 (2014).","DOI":"10.2147\/OTT.S65548"},{"key":"12963_CR58","doi-asserted-by":"publisher","unstructured":"Ding, N., Wu, H., Tao, T. & Peng, E. NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p\/BCL2. Onco Targets Ther. 4905\u20134915. https:\/\/doi.org\/10.2147\/OTT.S142446 (2017).","DOI":"10.2147\/OTT.S142446"},{"key":"12963_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/01.mpa.0000160282.64451.f1","volume":"30","author":"J Sharma","year":"2005","unstructured":"Sharma, J. et al. Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma. Pancreas30, 337\u2013342. https:\/\/doi.org\/10.1097\/01.mpa.0000160282.64451.f1 (2005).","journal-title":"Pancreas"},{"key":"12963_CR60","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3748\/wjg.v11.i18.2744","volume":"11","author":"M Dong","year":"2005","unstructured":"Dong, M. et al. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J. Gastroenterology: WJG. 11, 2744\u20132747. https:\/\/doi.org\/10.3748\/wjg.v11.i18.2744 (2005).","journal-title":"World J. Gastroenterology: WJG"},{"key":"12963_CR61","doi-asserted-by":"publisher","first-page":"296","DOI":"10.21608\/jbaar.2018.155808","volume":"4","author":"AA Abu Siyam","year":"2018","unstructured":"Abu Siyam, A. A., Demian, S. R., Ahmed, A. S., Ahmad, M. A. R. & Mersal, B. H. B cell Lymphoma-2 (Bcl-2) in serum increased with breast cancer in Egyptian women. J. Bioscience Appl. Res. 4, 296\u2013305. https:\/\/doi.org\/10.21608\/jbaar.2018.155808 (2018).","journal-title":"J. Bioscience Appl. Res."},{"key":"12963_CR62","doi-asserted-by":"publisher","unstructured":"Giannoulis, K. et al. Serum levels of bcl-2 in patients with colorectal cancer. Techniques in coloproctology 8, s56-s58 (2004). https:\/\/doi.org\/10.1007\/s10151-004-0112-2","DOI":"10.1007\/s10151-004-0112-2"},{"key":"12963_CR63","doi-asserted-by":"publisher","first-page":"894","DOI":"10.5966\/sctm.2015-0012","volume":"4","author":"TM Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez, T. M. et al. Effect of TGF-\u03b21 stimulation on the secretome of human adipose-derived mesenchymal stromal cells. Stem Cells Translational Med. 4, 894\u2013898. https:\/\/doi.org\/10.5966\/sctm.2015-0012 (2015).","journal-title":"Stem Cells Translational Med."},{"key":"12963_CR64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9, J. TGF\u03b2 in cancer. Cell 134, 215\u2013230. https:\/\/doi.org\/10.1016\/j.cell.2008.07.001 (2008).","journal-title":"Cell"},{"key":"12963_CR65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2015.02.049","volume":"562","author":"H Zhao","year":"2015","unstructured":"Zhao, H. et al. TGF-\u03b2\/Smad2\/3 signal pathway involves in U251 cell proliferation and apoptosis. Gene562, 76\u201382. https:\/\/doi.org\/10.1016\/j.gene.2015.02.049 (2015).","journal-title":"Gene"},{"key":"12963_CR66","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3390\/cancers12113099","volume":"12","author":"VW Xue","year":"2020","unstructured":"Xue, V. W. et al. Transforming growth factor-\u03b2: A multifunctional regulator of cancer immunity. Cancers12, 3099. https:\/\/doi.org\/10.3390\/cancers12113099 (2020).","journal-title":"Cancers"},{"key":"12963_CR67","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/labinvest.2015.57","volume":"95","author":"L Xiao","year":"2015","unstructured":"Xiao, L. et al. MicroRNA-129-5p modulates epithelial-to-mesenchymal transition by targeting SIP1 and SOX4 during peritoneal dialysis. Lab. Invest.95, 817\u2013832. https:\/\/doi.org\/10.1038\/labinvest.2015.57 (2015).","journal-title":"Lab. Invest."},{"key":"12963_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317706916","volume":"39","author":"L Yan","year":"2017","unstructured":"Yan, L. et al. MiR-129-5p influences the progression of gastric cancer cells through interacting with SPOCK1. Tumor Biol.39, 1010428317706916. https:\/\/doi.org\/10.1177\/1010428317706916 (2017).","journal-title":"Tumor Biol."},{"key":"12963_CR69","doi-asserted-by":"publisher","unstructured":"Li, Y. et al. Niao Du Kang Mixture Increases the Expression of mir-129\u20105p to Relieve Renal Fibrosis. Evidence\u2010Based Complementary and Alternative Medicine. 1841890 (2020). (2020). https:\/\/doi.org\/10.1155\/2020\/1841890","DOI":"10.1155\/2020\/1841890"},{"key":"12963_CR70","doi-asserted-by":"publisher","first-page":"530","DOI":"10.12659\/MSM.890531","volume":"20","author":"D S\u00fcren","year":"2014","unstructured":"S\u00fcren, D. et al. The role of high mobility group box 1 (HMGB1) in colorectal cancer. Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res. 20, 530\u2013537. https:\/\/doi.org\/10.12659\/MSM.890531 (2014).","journal-title":"Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res."},{"key":"12963_CR71","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/biomedicines11072058","volume":"11","author":"A Boicean","year":"2023","unstructured":"Boicean, A. et al. Has-miR-129-5p\u2019s involvement in different disorders, from digestive cancer to neurodegenerative diseases. Biomedicines 11, 2058. https:\/\/doi.org\/10.3390\/biomedicines11072058 (2023).","journal-title":"Biomedicines"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12963-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12963-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12963-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T01:03:21Z","timestamp":1753923801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12963-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12963"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12963-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of the Cairo University\u2019s Faculty of Pharmacy\u2019s with approval number (BC3568), and all methods were performed in accordance with relevant guidelines and regulations. The study has been conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The written informed consent was obtained from all subjects in advance.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"27638"}}